Secondary insomnia in the primary care setting: review of diagnosis, treatment, and management

References

• Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994;151:1172–80
   Google Scholar
• Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989;262:1479–84
   PubMed Web of Science ®Google Scholar
• National Sleep Foundation. 2002 sleep in America poll. Washington, DC: WB & A Market Research, 2002. pp.1–43
   Google Scholar
• National Sleep Foundation. Sleep in America: 1995 Gallup poll, 1999
   Google Scholar
• Leger D, Guilleminault C, Bader G, et al. Medical and socio-professional impact of insomnia. Sleep 2002;25:625–29
   PubMed Web of Science ®Google Scholar
• Hajack G. Insomnia in primary care. Sleep 2000;23:S54–63
   PubMedGoogle Scholar
• Israel AG, Lieberman JA. Tackling insomnia: diagnostic and treatment issues in primary care. In: Roberts WO, editor. Insomnia in primary care: a postgraduate medicine special report. Minneapolis: McGraw-Hill Healthcare Information Group, 2004 pp.7–13
   Google Scholar
• Buysse DJ, Reynolds CF III, Kupfer DJ, et al. Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV Field Trial. Sleep 1994;17:630–7
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders – text revision. 4th edn. Washington, DC: American Psychiatric Publishing Inc., 2000
   Google Scholar
• Shochat T, Umphress J, Israel AG, et al. Insomnia in primary care patients. Sleep 1999;22:S359–65
   PubMed Web of Science ®Google Scholar
• Dorrepaal KL, Aaronson NK, van Dam FS. Pain experience and pain management among hospitalized cancer patients. A clinical study. Cancer 1989;63:593–8
   Google Scholar
• McCrae CS, Lichstein KL. Managing insomnia in long-term care. Annals of Long-term Care 2002;10:38–43
   Google Scholar
• Doghramji K. The need for flexibility in dosing of hypnotic agents. Sleep 2000;23:S16–20
   PubMed Web of Science ®Google Scholar
• Liu X, Uchiyama M, Kim K, et al. Sleep loss and daytime sleepiness in the general adult population of Japan. Psychiatry Res 2000;93:1–11
   PubMed Web of Science ®Google Scholar
• Nugent AM, Gleadhill I, McCrum E, et al. Sleep complaints and risk factors for excessive daytime sleepiness in adult males in Northern Ireland. J Sleep Res 2001;10:69–74
   PubMed Web of Science ®Google Scholar
• Ohayon MM, Zulley J. Correlates of global sleep dissatisfaction in the German population. Sleep 2001;24:780–7
   PubMed Web of Science ®Google Scholar
• Lichstein KL, McCrae CS, Wilson NM. Secondary Insomnia: diagnostic issues, cognitive-behavioral treatment, and future directions. In: Lichstein KL, Morin CM, editors. Treatment of late-life insomnia. Thousand Oaks, CA: Sage, 2000
   Google Scholar
• Lichstein KL, Nau SD, McCrae CS, et al. Chapter 62. Psychological and behavioral treatments for secondary insomnias. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine, 4th edn. Philadelphia, PA: Elsevier Saunders, 2005
   Google Scholar
• Thase ME. Correlates and consequences of chronic insomnia. Gen Hosp Psych 2005;27:100–12
   PubMed Web of Science ®Google Scholar
• Martinez-Gonzalez D, Obermeyer WH, Benca RM. Comorbidity of insomnia with medical and psychiatric disorders. Primary Psychiatry 2002;9:37–49
   Google Scholar
• Consensus Development Panel. National Institutes of Health Consensus Development conference statement: the treatment of sleep disorders of older people. March 26–28, 1990. Sleep 1991;14: 169–77
   Google Scholar
• Mendelson WB. Effects of flurazepam and zolpidem on the perception of sleep in insomniacs. Sleep 1995;18:92–6
   PubMed Web of Science ®Google Scholar
• Walsh JK, Sugerman JL. Disorder of initiating and maintaining sleep in adult psychiatric disorders. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. Philadelphia: W B Saunders, 1989. pp.448–55
   Google Scholar
• Lichstein KL. Secondary insomnia. In: Lichstein KL, Morin CM, editors. Treatment of late-life insomnia. Thousand Oaks, CA: Sage, 2000. pp.297–319
   Google Scholar
• Reynolds CF III, Hoch CC, Buysse DJ, et al. Sleep in late-life recurrent depression. Changes during early continuation therapy with nortriptyline. Neuropsychopharmacology 1991;5: 85–96
   Google Scholar
• Londborg PD, Smith WT, Glaudin V, et al. Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. J Affect Disord 2000;61:73–9
   PubMed Web of Science ®Google Scholar
• Nowlin-Finch NL, Altshuler LL, Szuba MP, et al. Rapid resolution of first episodes of mania: sleep related? J Clin Psychiatry 1994;55:26–9
   Google Scholar
• Morawetz D. Depression and insomnia. Aust Fam Physician 2000;29:1016
   PubMedGoogle Scholar
• Walsh JK, Muehlbach MJ, Lauter SA, et al. Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis. J Rheumatol 1996;23:245–52
   PubMed Web of Science ®Google Scholar
• Buysse DJ. Insomnia, depression and aging. Assessing sleep and mood interactions in older adults. Geriatrics 2004;59:47–51
   Google Scholar
• Lichstein KL, Durrence HH, Riedel BW, et al. Epidemiology of sleep: age, gender, and ethnicity. Mahway, NJ: Lawrence Erlbaum Associates, 2004
   Google Scholar
• Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract 2002;51:229–35
   PubMed Web of Science ®Google Scholar
• Bixler EO, Kales A, Soldatos CR, et al. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 1979;136:1257–62
   PubMed Web of Science ®Google Scholar
• Chevalier H, Los F, Boichut D, et al. Evaluation of severe insomnia in the general population: results of a European multinational survey. J Psychopharmacol 1999;13:S21–4
   PubMed Web of Science ®Google Scholar
• Hohagen F, Rink K, Kappler C, et al. Prevalence and treatment of insomnia in general practice. A longitudinal study. Eur Arch Psychiatry Clin Neurosci 1993;242:329–36
   PubMed Web of Science ®Google Scholar
• Vollrath M, Wicki W, Angst J. The Zurich study. VIII. Insomnia: association with depression, anxiety, somatic syndromes, and course of insomnia. Eur Arch Psychiatry Neurol Sci 1989;239:113–24
   Google Scholar
• Zeitlhofer J, Rieder A, Kapfhammer G, et al. Epidemiology of sleep disorders in Austria. Wien Klin Wochenschr 1994;106:86–8
   PubMed Web of Science ®Google Scholar
• Radecki SE, Brunton SA. Management of insomnia in office-based practice. National prevalence and therapeutic patterns. Arch Fam Med 1993;2:1129–34
   PubMedGoogle Scholar
• Ohayon MM, Partinen M. Insomnia and global sleep dissatisfaction in Finland. J Sleep Res 2002;11:339–46
   PubMed Web of Science ®Google Scholar
• Weyerer S, Dilling H. Prevalence and treatment of insomnia in the community: results from the Upper Bavarian Field Study. Sleep 1991;14:392–8
   PubMed Web of Science ®Google Scholar
• Wooten VD, Buysse DJ. Sleep in psychiatric disorders. In: Chokroverty S, Daroff RB, editors. Sleep disorders medicine: basic sciences, technical considerations, and clinical aspects. Boston, MA: Butterworth-Heinemann Medical, 1999. pp.573–86
   Google Scholar
• Chokroverty S. Clinical companion to sleep disorders medicine. 2nd edn. Boston, MA: Butterworth-Heinemann, 2000
   Google Scholar
• Reite M, Ruddy J, Nagel K. Insomnia complaints. Concise guide to evaluation and management of sleep disorders. Washington, DC: American Psychiatric Press Inc., 1997. pp.47–112
   Google Scholar
• McCracken LM, Iverson GL. Disrupted sleep patterns and daily functioning in patients with chronic pain. Pain Res Manag 2002;7:75–9
   PubMedGoogle Scholar
• Barbar SI, Enright PL, Boyle P, et al. Sleep disturbances and their correlates in elderly Japanese American men residing in Hawaii. J Gerontol A Biol Sci Med Sci 2000;55:M406–11
   PubMed Web of Science ®Google Scholar
• Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985;42:225–32
   Google Scholar
• Moul DE, Nofzinger EA, Pilkonis PA, et al. Symptom reports in severe chronic insomnia. Sleep 2002;25:553–63
   PubMed Web of Science ®Google Scholar
• Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep 1999;22:S386–93
   PubMed Web of Science ®Google Scholar
• Stoller MK. Economic effects of insomnia. Clin Ther 1994;16:873–97
   PubMed Web of Science ®Google Scholar
• Ringdahl EN, Pereira SL, Delzell JE. Treatment of primary insomnia. J Am Board Fam Pract 2004;17:212–9
   PubMedGoogle Scholar
• Doghramji P. Detection of insomnia in primary care. J Clin Psychiatry 2001;62:18–26
   PubMed Web of Science ®Google Scholar
• Ancoli-Israel S. Insomnia in the elderly: a review for the primary care practitioner. Sleep 2000;23:S23–30
   PubMed Web of Science ®Google Scholar
• Buysse DJ, Reynolds CF, Monk TH, et al. Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index (PSQI). Sleep 1991;14:331–8
   PubMed Web of Science ®Google Scholar
• Thase ME, Nirenberg AA, Keller MB, et al. Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients. J Clin Psychiatry 2001;62:782–88
   PubMed Web of Science ®Google Scholar
• IMS Health. National Prescription Audit™, 2003
   Google Scholar
• Buysse DJ, Reynolds CF. Pharmacologic treatment. In: Lichstein KL, Morin CM, editors. Treatment of late-life insomnia. Thousand Oaks, CA: Sage, 2000. pp.231–67
   Google Scholar
• Mendelson WB, Roth T, Cassella T, et al. The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 new clinical drug evaluation unit meeting symposium. Sleep Med Rev 2004;8:7–17
   Google Scholar
• Pagel JF, Parnes BL. Medications for the treatment of sleep disorders: an overview. Prim Care Companion J Clin Psychiatry. 2001;3:118–25
   PubMedGoogle Scholar
• Kirkwood CK. Management of insomnia. J Am Pharm Assoc (Wash) 1999;39:688–96
   PubMedGoogle Scholar
• Langer S, Mendelson W, Richardson G. Symptomatic treatment of insomnia. Sleep 1999;33:S437–45
   Google Scholar
• Kales A, Manfredi RL, Vgontzas AW, et al. Clinical trials and therapeutics: rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines. Clin Pharmacol Ther 1991;49:468–76
   PubMed Web of Science ®Google Scholar
• Montplaisir R, Hawa H, Moller C, et al. Zopiclone and zaleplon vs benzodiazepines in the treatment of insomnia: Canadian consensus statement. Hum Psychopharmacol Clin Exp 2003;18:29–38
   PubMed Web of Science ®Google Scholar
• Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989;262:3303–7
   Google Scholar
• Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995;332:767–73
   PubMed Web of Science ®Google Scholar
• Carskadon MA, Seidel WF, Greenblatt DJ, et al. Daytime carryover of triazolam and flurazepam in elderly insomniacs. Sleep 1982;5:361–71
   PubMed Web of Science ®Google Scholar
• Cumming RG, Klineberg RJ. Psychotropics, thiazide diuretics and hip fractures in the elderly. Med J Aust 1993;158:414–7
   PubMed Web of Science ®Google Scholar
• Wysowski DK, Baum C, Ferguson WJ, et al. Sedative-hypnotic drugs and the risk of hip fracture. J Clin Epidemiol 1996; 49:111–3
   PubMed Web of Science ®Google Scholar
• Pierfitte C, Macouillard G, Thicoipe M, et al. Benzodiazepines and hip fractures in elderly people: case-control study. BMJ 2001;322:704–8
   PubMed Web of Science ®Google Scholar
• Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med 1991;324:1326–31
   PubMed Web of Science ®Google Scholar
• Herings RM, Stricker BH, de Boer A, et al. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med 1995;155:1801–7
   Google Scholar
• Wang PS, Bohn RL, Glynn RJ, et al. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001;158:892–8
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (part I). Clin Pharmacokinet 1991;21:165–77
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Harmatz JS, Shapiro L, et al. Sensitivity to triazolam in the elderly. N Engl J Med 1991;324:1691–8
   PubMed Web of Science ®Google Scholar
• Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987;316:363–9
   PubMed Web of Science ®Google Scholar
• Neutel CI, Hirdes JP, Maxwell CJ, et al. New evidence on benzodiazepine use and falls: the time factor. Age Ageing 1996;25:273–8
   PubMed Web of Science ®Google Scholar
• Kupfer DJ, Reynolds CF III. Management of insomnia. N Engl J Med 1997;336:341–6
   PubMed Web of Science ®Google Scholar
• Sadavoy J, Lazarus LW, Jarvik LF, et al. Comprehensive review of geriatric psychiatry. 2nd edn. Washington, DC: American Psychiatric Press, 1996
   Google Scholar
• Tinetti ME. Preventing falls in elderly persons. N Engl J Med 2003;348:42–8
   PubMed Web of Science ®Google Scholar
• Grad RM. Benzodiazepines for insomnia in community-dwelling elderly: a review of benefit and risk. J Fam Pract 1995;41: 473–81
   PubMed Web of Science ®Google Scholar
• Scharf MB, Roth T, Vogel GW, et al. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry 1994;55:192–9
   PubMed Web of Science ®Google Scholar
• Ware JC, Walsh JK, Scharf MB, et al. Minimal rebound insomnia after treatment with 10 mg zolpidem. Clin Neuropharmacol 1997;20:116–25
   PubMed Web of Science ®Google Scholar
• Walsh JK, Erman M, Erwin CW, et al. Subjective hypnotic efficacy of trazodone and zolpidem in DSM-III-R primary insomnia. Hum Psychopharm 1998;13:191–8
   Web of Science ®Google Scholar
• Hajak G, Cluydts R, Declerck A, et al. Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study. Int Clin Psychopharmacol 2002;17:9–17
   PubMed Web of Science ®Google Scholar
• Elie R, Ruther E, Farr I, et al. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group. J Clin Psychiatry 1999;60:536–44
   PubMed Web of Science ®Google Scholar
• Fry J, Scharf M, Mangano R, et al. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group. Int Clin Psychopharmacol 2000;15:141–52
   PubMed Web of Science ®Google Scholar
• Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003;26:793–9
   PubMed Web of Science ®Google Scholar
• Zammit GK, McNabb LJ, Caron J, et al. Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Curr Med Res Opin 2004;20:1979–91
   PubMed Web of Science ®Google Scholar
• Walsh JK, Roth T, Randazzo A, et al. Eight weeks of non-nightly use of zolpidem for primary insomnia. Sleep 2000;23: 1087–96
   PubMed Web of Science ®Google Scholar
• Hesse LM, von Moltke LL, Greenblatt DJ. Clinically important drug interactions with zopiclone, zolpidem and zaleplon. CNS Drugs 2003;17:513–32
   PubMed Web of Science ®Google Scholar
• Hedner J, Yaeche R, Emilien G, et al. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group. Int J Geriatr Psychiatry 2000;15:704–12
   PubMed Web of Science ®Google Scholar
• Dockhorn RJ, Dockhorn DW. Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial. Clin Neuropharmacol 1996; 19:333–40
   PubMed Web of Science ®Google Scholar
• Shaw SH, Curson H, Coquelin JP. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients. J Int Med Res 1992;20:150–61
   Google Scholar
• Zolpidem PI, sanofi-aventis, Bridgewater, NJ, 2005
   Google Scholar
• Kales A, Manfredi RL, Vgontzas AN, et al. Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines. Clin Pharmacol Ther 1991;49:468–76
   PubMed Web of Science ®Google Scholar
• Mitler MM, Seidel WF, van den HJ, et al. Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study. J Clin Psychopharmacol 1984;4:2–13
   PubMed Web of Science ®Google Scholar
• Roehrs T, Vogel G, Vogel F, et al. Dose effects of temazepam tablets on sleep. Drugs Exp Clin Res 1986;12:693–9
   PubMedGoogle Scholar
• Gringras M, Beaumont G, Ankier SI. A comparison of the hypnotic activity of loprazolam, temazepam and placebo in general practice. J Int Med Res 1984;12:10–6
   Google Scholar
• Allen RP, Mendels J, Nevins DB, et al. Efficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three months. J Clin Pharmacol 1987;27:768–75
   PubMed Web of Science ®Google Scholar
• Parrino L, Spaggiari MC, Boselli M, et al. Clinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia. Psychopharmacology (Berl) 1994;116:389–95
   PubMed Web of Science ®Google Scholar
• Mouret J, Lemoine P, Minuit MP, et al. Effects of trazodone on the sleep of depressed subjects – a polygraphic study. Psychopharmacology (Berl) 1988;95:S37–43
   PubMed Web of Science ®Google Scholar
• Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:249–60
   PubMed Web of Science ®Google Scholar
• Montgomery I, Oswald I, Morgan K, et al. Trazodone enhances sleep in subjective quality but not in objective duration. Br J Clin Pharmacol 1983;16:139–44
   PubMed Web of Science ®Google Scholar
• Blacker R, Shanks NJ, Chapman N, et al. The drug treatment of depression in general practice: a comparison of nocte administration of trazodone with mianserin, dothiepin and amitriptyline. Psychopharmacology (Berl) 1988;95:S18–24
   PubMed Web of Science ®Google Scholar
• Haria M, Fitton A, McTavish D. Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging 1994;4:331–55
   Google Scholar
• Nowell PD, Buysse DJ. Treatment of insomnia in patients with mood disorders. Depress Anxiety 2001;14:7–18
   PubMed Web of Science ®Google Scholar
• Coursey RD, Buchsbaum M, Frankel BL. Personality measures and evoked responses in chronic insomniacs. J Abnorm Psychol 1975;84:239–49
   PubMed Web of Science ®Google Scholar
• Beutler LE. Psychological variables in the diagnosis of insomnia. In: Williams RL, Karacan I, editors. Sleep disorders: diagnosis and treatment. New York: John Wiley & Sons; 1978. pp.61–100
   Google Scholar
• Bonnet MH, Arand DL. 24-hour metabolic rate in insomniacs and matched normal sleepers. Sleep 1995;18:581–8
   PubMed Web of Science ®Google Scholar
• Vandeputte M, de Weerd A. Sleep disorders and depressive feelings: a global survey with the Beck depression scale. Sleep Med 2003;4:343–5
   PubMed Web of Science ®Google Scholar
• Chang PP, Ford DE, Mead LA, et al. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 1997;146:105–14
   Google Scholar
• Breslau N, Roth T, Rosenthal L, et al. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 1996;39:411–8
   PubMed Web of Science ®Google Scholar
• Livingston G, Blizard B, Mann A. Does sleep disturbance predict depression in elderly people? A study in inner London. Br J Gen Pract 1993;43:445–8
   Google Scholar
• Perlis ML, Giles DE, Buysse DJ, et al. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord 1997;42:209–12
   PubMed Web of Science ®Google Scholar
• Lustberg L, Reynolds CF. Depression and insomnia: questions of cause and effect. Sleep Med Rev 2000;4:253–62
   PubMed Web of Science ®Google Scholar
• Rush CR. Behavioral pharmacology of zolpidem relative to benzodiazepines: a review. Pharmacol Biochem Behav 1998;61:253–69
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Rush AJ, Armitage R, et al. Effects of fluoxetine on the polysomnogram in outpatients with major depression. Neuropsychopharmacology 1999;20:447–59
   PubMed Web of Science ®Google Scholar
• Dorsey CM, Lukas SE, Cunningham SL. Fluoxetine-induced sleep disturbance in depressed patients. Neuropsychopharmacology 1996;14:437–42
   Google Scholar
• Rudolph RL, Fabre LF, Feighner JP, et al. A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression. J Clin Psychiatry 1998;59:116–22
   PubMed Web of Science ®Google Scholar
• Thase ME. Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group. J Clin Psychiatry 1997;58:393–8
   PubMed Web of Science ®Google Scholar
• Salin-Pascual RJ, Galicia-Polo L, Drucker-Colin R. Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers. J Clin Psychiatry 1997;58:348–50
   PubMed Web of Science ®Google Scholar
• Luthringer R, Toussaint M, Schaltenbrand N, et al. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression. Psychopharmacol Bull 1996;32:637–46
   PubMed Web of Science ®Google Scholar
• Chalon S, Pereira A, Lainey E, et al. Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects. Psychopharmacology (Berl) 2005;177:357–65
   PubMed Web of Science ®Google Scholar
• Karacan I, Thornby JI, Anch M, et al. Prevalence of sleep disturbance in a primarily urban Florida County. Soc Sci Med 1976;10:239–44
   PubMed Web of Science ®Google Scholar
• Sutton DA, Moldofsky H, Badley EM. Insomnia and health problems in Canadians. Sleep 2001;24:665–70
   Google Scholar
• Gislason T, Almqvist M. Somatic diseases and sleep complaints. An epidemiological study of 3201 Swedish men. Acta Med Scand 1987;221:475–81
   Google Scholar
• Moldofsky H, Scarisbrick P, England R, et al. Musculosketal symptoms and non-REM sleep disturbance in patients with ‘fibrositis syndrome’ and healthy subjects. Psychosom Med 1975;37:341–51
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160–72
   PubMed Web of Science ®Google Scholar
• Wilson KG, Eriksson MY, D’Eon JL, et al. Major depression and insomnia in chronic pain. Clin J Pain 2002;18:77–83
   PubMed Web of Science ®Google Scholar
• White KP, Speechley M, Harth M, et al. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 1999;26:1577–85
   PubMed Web of Science ®Google Scholar
• Nicassio PM, Moxham EG, Schuman CE, et al. The contribution of pain, reported sleep quality, and depressive symptoms to fatigue in fibromyalgia. Pain 2002;100:271–9
   PubMed Web of Science ®Google Scholar
• Affleck G, Urrows S, Tennen H, et al. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain 1996;68:363–8
   PubMed Web of Science ®Google Scholar
• Paiva T, Batista A, Martins P, et al. The relationship between headaches and sleep disturbances. Headache 1995;35:590–6
   PubMed Web of Science ®Google Scholar
• Paiva T, Farinha A, Martins A, et al. Chronic headaches and sleep disorders. Arch Intern Med 1997;157:1701–5
   PubMed Web of Science ®Google Scholar
• Roizenblatt S, Moldofsky H, Benedito-Silva AA, et al. Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 2001;44:222–30
   PubMed Web of Science ®Google Scholar
• Branco J, Atalaia A, Paiva T. Sleep cycles and alpha-delta sleep in fibromyalgia syndrome. J Rheumatol 1994;21:1113–7
   Google Scholar
• Drewes AM, Gade K, Nielsen KD, et al. Clustering of sleep electroencephalographic patterns in patients with the fibromyalgia syndrome. Br J Rheumatol 1995;34:1151–6
   PubMedGoogle Scholar
• Nielsen KD, Drewes AM, Svendsen L, et al. Ambulatory recording and power spectral analysis by autoregressive modelling of polygraphic sleep signals in patients suffering from chronic pain. Methods Inf Med 1994;33:76–8
   PubMed Web of Science ®Google Scholar
• Strang P. Emotional and social aspects of cancer pain. Acta Oncol 1992;31:323–6
   PubMed Web of Science ®Google Scholar
• Koopman C, Nouriani B, Erickson V, et al. Sleep disturbances in women with metastatic breast cancer. Breast J 2002;8:362–70
   PubMedGoogle Scholar
• Fortner BV, Stepanski EJ, Wang SC, et al. Sleep and quality of life in breast cancer patients. J Pain Symptom Manage 2002;24:471–80
   PubMed Web of Science ®Google Scholar
• O’Bryant SE, Palav A, McCaffrey RJ. A review of symptoms commonly associated with menopause: implications for clinical neuropsychologists and other health care providers. Neuropsychol Rev 2003;13:145–52
   Google Scholar
• Shaver JL. Women and sleep. Nurs Clin North Am 2002;37: 707–18
   PubMed Web of Science ®Google Scholar
• Joffe H, Soares CN, Cohen LS. Assessment and treatment of hot flushes and menopausal mood disturbance. Psychiatr Clin North Am 2003;26:563–80
   Google Scholar
• Woodward S, Freedman RR. The thermoregulatory effects of menopausal hot flashes on sleep. Sleep 1994;17:497–501
   PubMed Web of Science ®Google Scholar
• Shaver J, Giblin E, Lentz M, et al. Sleep patterns and stability in perimenopausal women. Sleep 1988;11:556–61
   PubMed Web of Science ®Google Scholar
• Erlik Y, Tataryn IV, Meldrum DR, et al. Association of waking episodes with menopausal hot flushes. JAMA 1981;245: 1741–4
   PubMed Web of Science ®Google Scholar
• Moe KE. Reproductive hormones, aging, and sleep. Semin Reprod Endocrinol 1999;17:339–48
   PubMedGoogle Scholar
• Krystal AD, Edinger J, Wohlgemuth WK, et al. Sleep in perimenopausal and post-menopausal women. Sleep Med Rev 1998;2:243–53
   PubMedGoogle Scholar
• National Heart Lung and Blood Institute Working Group on Insomnia. Insomnia: assessment and management in primary care. Am Fam Physician 1999;59:3029–38
   PubMedGoogle Scholar
• McCall WV. Management of primary sleep disorders among elderly persons. Psychiatr Serv 1995;46:49–55
   PubMed Web of Science ®Google Scholar
• Vincent N, Lionberg C. Treatment preference and patient satisfaction in chronic insomnia. Sleep 2001;24:411–7
   PubMed Web of Science ®Google Scholar
• Morin CM, Hauri PJ, Espie CA, et al. Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 1999;22:1134–56
   PubMed Web of Science ®Google Scholar
• Asnis GM, Chakraburtty A, DuBoff EA, et al. Zolpidem in SSRI-treated patients with persistent insomnia. J Clin Psychiatry 1999;60:668–76
   PubMed Web of Science ®Google Scholar
• Scharf MB, McDannold MD, Stover R, et al. Effects of estrogen replacement therapy on rates of cyclic alternating patterns and hot-flush events during sleep in postmenopausal women: a pilot study. Clin Ther 1997;19:304–11
   PubMed Web of Science ®Google Scholar
• Purdie DW, Empson JA, Crichton C, et al. Hormone replacement therapy, sleep quality and psychological wellbeing. Br J Obstet Gynaecol 1995;102:735–9
   PubMedGoogle Scholar
• Polo-Kantola P, Erkkola R, Helenius H, et al. When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol 1998;178:1002–9
   Google Scholar